Canonica's research areas primarily include the observations of molecular events, which further includes interactivity of epithelial cells, inflammatory cells and immunocompetent cells in allergic inflammation and airway remodeling. He is also known to be involved in innovative treatment strategies for allergic diseases including biological response modifier in form of targeted immunotherapy with primary emphasis on sublingual immunotherapy (SLIT).